Articles by tag: mrna-vaccine

Moderna's personalized mRNA vaccine against pancreatic cancer: 78% effect

Moderna released a personalized mRNA vaccine against pancreatic cancer: remission in 78% of patients over 18 months. FDA accelerated approval. Analysis of efficacy and risks.

mRNA vaccines became 3 times more effective: breakthrough by Mt Sinai

Mount Sinai scientists refuted the dogma of mRNA vaccine function. Suppressing expression in the liver triples the immune response. Learn about the revolution in cancer therapy and toxicity reduction.